Lemaitre Vascular Inc. (LMAT)
NASDAQ · Healthcare
Lemaitre Vascular Inc. Shareholder Equity 2020–2025
Lemaitre Vascular Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Lemaitre Vascular Inc. shareholder equity as of December 31, 2025: 393.5M, a 16.67% increase year-over-year.
- Lemaitre Vascular Inc. shareholder equity for 2025 were 393.5M, a 16.67% increase from 2024.
- Lemaitre Vascular Inc. shareholder equity for 2024 were 337.3M, a 13.22% increase from 2023.
- Lemaitre Vascular Inc. shareholder equity for 2023 were 297.9M, a 11.07% increase from 2022.
- Lemaitre Vascular Inc. shareholder equity for 2022 were 268.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Lemaitre Vascular Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $394 |
| 2024 | $337 |
| 2023 | $298 |
| 2022 | $268 |
| 2021 | $254 |
| 2020 | $173 |
Lemaitre Vascular Inc. Shareholder Equity — FAQ
Lemaitre Vascular Inc. (LMAT) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LMAT's shareholder equity history?
The chart and table above show Lemaitre Vascular Inc.'s shareholder equity by year and by quarter, including the growth rate.